Laird Superfood is no longer a single-brand creamer company trying to earn its keep in grocery. Two acquisitions in a single spring, financed entirely with convertible preferred from Nexus Capital, turned a specialty brand into a three-banner functional-nutrition platform. The investment debate is whether the common equity still owns a meaningful residual after that preferred stack, or whether scale arrived by handing control and most of the economics to the new sponsor. The share price sits near the preferred conversion level, which is the market's way of saying the stub is live but thin.
The Terrasoul Superfoods close in April, stacked on the March Navitas Organics purchase, is the event that changes the residual claim. Terrasoul brought a vertically integrated Fort Worth plant and a large marketplace franchise. Navitas brought a two-decade grocery brand in organic superfoods. Both deals were funded with Series A preferred that converts at a fixed price and pays a five percent coupon. The mechanism is simple. The company bought scale, and the sponsor bought the company. Common holders now sit behind a liquidation preference larger than the public float and a voting block that already controls the board.
Gross margin is the tension the income statement already shows. Adding Terrasoul's lower-margin ingredient mix, plus commodity inflation, pulled second-quarter gross profit down from the high thirties the old Laird brand used to print. Adjusted earnings before interest, taxes, depreciation, and amortization flipped positive on the combined base, but only after adding back several million of deal and integration costs. The old path-to-profit story on a high-margin creamer mix is not the same story as a roll-up whose biggest brand sells nuts and seeds online. Net sales printed $41.3 million in the second quarter. That is more than triple the year-ago quarter, and almost all of the jump is purchased scale rather than same-store creamers.
The next several prints decide whether Walmart velocity, Navitas grocery expansion, and Fort Worth plant utilization can lift the combined margin while the preferred coupon quietly compounds. Management reaffirmed full-year sales between $138 million and $148 million. Adjusted EBITDA guidance sits in a high-single-digit to low-double-digit million range that assumes synergy capture. If those ranges hold and cash from operations covers the coupon, the common stub has a path. If mix stays heavy and integration costs linger, the preferred keeps compounding against a shrinking residual.